Aditi Dhar has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
DSFCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aditi Dhar has reported an acquisition of 2,55,452 shares (0.29% of diluted share capital) of DCM Shriram Fine Chemicals Limited from Tilak Dhar & Sons (HUF) on 30 March 2026. The transaction is not a market purchase but arises from the distribution of assets through partition of a Hindu Undivided Family. As a result, the shareholding of Urvashi Tilak Dhar (Constituted Attorney of the acquirer) increased from 12,71,313 shares (1.46%) to 15,26,765 shares (1.76%). The acquirer has relied on the exemption under Regulation 10(1)(a)(i) of the SEBI (SAST) Regulations, which allows inter se transfers within the promoter/promoter group without triggering an open offer.
This is an internal family/HUF restructuring, not a market transaction, so there is no direct impact on the stock price or free-float. Existing shareholders are not affected, and no open offer obligation arises from this transfer.